Artivion (AORT) Acquisitions (2012 - 2020)

Artivion (AORT) posted Acquisitions of -$524000.0 for Q4 2020, up 99.42% on a QoQ basis from -$89.9 million in Q3 2016.

Artivion (AORT) Acquisitions (2012 - 2020) Analysis & Trends

Artivion's Acquisitions history runs 3 years deep, the most recent figure standing at -$524000.0 for Q4 2020.

  • Quarterly Acquisitions changed N/A year-over-year to -$524000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was -$90.4 million (changed N/A YoY) and the FY2020 annual result came in at $59.1 million, changed N/A from the prior year.
  • Acquisitions was -$524000.0 for Q4 2020 at Artivion, up from -$89.9 million in the prior quarter.
  • Across five years, Acquisitions topped out at $91.2 million in Q1 2016 and bottomed at -$89.9 million in Q3 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 22.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 406.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 523.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -268.10 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 2.30 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Artivion 1.25 Bn 1.19 Bn 75.45 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2020 -524,000.00
Sep 30, 2016 -89.93 Mn
Mar 31, 2016 91.15 Mn
Sep 30, 2012 -15,000.00